In addition, our data strongly supports that IHC using an efficient anti-FAIM2 antibody can be very helpful for diagnosing SCLC, and that FAIM2 may be more specific for SCLC than established NE markers such as synaptophysin2. Here, FAIM2 is linked to small cell lung carcinoma.